← Open Payments lookup

JULIA BOOTHE: Open Payments

NPI 1255397824 · REFORM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,821 in 98 payments from 21 companies in 2025. Trend: 2023 $1,597 · 2024 $1,646 · 2025 $1,821

Food & beverage: $1,821
CompanyPaymentsAmount
ABBVIE INC.19$305
Vanda Pharmaceuticals Inc.16$300
Otsuka America Pharmaceutical, Inc.11$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$125
Novo Nordisk Inc6$116
Ardelyx, Inc.5$108
Novartis Pharmaceuticals Corporation4$102
Neurocrine BioSciences, Inc.5$92
Bayer Healthcare Pharmaceuticals Inc.4$92
GlaxoSmithKline, LLC.5$82

Products named: FANAPT, REXULTI, VRAYLAR, CAPLYTA, IBSRELA, LEQVIO, INGREZZA, Kerendia.

Industry payments across AL — which companies pay providers there.